Recursion Pharmaceuticals adds FAP and C diff clinical trials labiotech.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labiotech.eu Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced the.